Literature DB >> 21277301

Loss of Runx3 is a key event in inducing precancerous state of the stomach.

Kosei Ito1, Linda Shyue Huey Chuang, Tomoko Ito, Ti Ling Chang, Hiroshi Fukamachi, Manuel Salto-Tellez, Yoshiaki Ito.   

Abstract

BACKGROUND & AIMS: RUNX3 is a tumor suppressor originally identified in gastric cancer. The mutation R122C in RUNX3 promotes gastric carcinogenesis by unclear mechanisms. We investigated how Runx3-deficiency contributes to distinct changes in the gastric epithelium that precede neoplasia.
METHODS: Runx3-deficient (Runx3(-/-)) and wild-type BALB/c adult mice were subjected to histological analyses. Gastric cancer formation after administration of N-methyl-N-nitrosourea was evaluated. Runx3(+/+) and Runx3(-/-) gastric epithelial cell lines were used to investigate the molecular basis underlying Runx3 function.
RESULTS: The gastric epithelia in Runx3(-)/(-) adult mice was hyperplastic, with loss of chief cells and development of mucin 6- and trefoil factor-2-expressing metaplasia. The gastric epithelium of Runx3(-)/(-) mice had an intestinal phenotype that expressed Cdx2. After addition of N-methyl-N-nitrosourea, Runx3- mice, unlike wild-type mice, consistently developed adenocarcinomas, indicating that Runx3-deficiency leads to premalignant changes in the gastric epithelia. RUNX3, but not the RUNX3 mutant R122C, repressed Cdx2 expression by attenuation of oncogenic beta(symbol)-catenin and Tcfs.
CONCLUSIONS: Runx3-deficiency leads to a precancerous state in the gastric epithelia of mice, characterized by loss of chief cells but not parietal cells; inflammation did not appear to be involved.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277301     DOI: 10.1053/j.gastro.2011.01.043

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

1.  Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Authors:  Victoria G Weis; Josane F Sousa; Bonnie J LaFleur; Ki Taek Nam; Jared A Weis; Paul E Finke; Nadia A Ameen; James G Fox; James R Goldenring
Journal:  Gut       Date:  2012-07-07       Impact factor: 23.059

Review 2.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

Review 3.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 4.  Roles of RUNX in Hippo Pathway Signaling.

Authors:  Antonino Passaniti; Jessica L Brusgard; Yiting Qiao; Marius Sudol; Megan Finch-Edmondson
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 5.  The RUNX family: developmental regulators in cancer.

Authors:  Yoshiaki Ito; Suk-Chul Bae; Linda Shyue Huey Chuang
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

Review 6.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  Abnormal liver differentiation and excessive angiogenesis in mice lacking Runx3.

Authors:  Jong-Min Lee; Dong-Joon Lee; Suk-Chul Bae; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2013-01-31       Impact factor: 4.304

Review 8.  New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2.

Authors:  Jimin Min; Tae-Su Han; Yoojin Sohn; Takahiro Shimizu; Boram Choi; Seong-Woo Bae; Keun Hur; Seong-Ho Kong; Yun-Suhk Suh; Hyuk-Joon Lee; Jang-Seong Kim; Jeong-Ki Min; Woo-Ho Kim; V Narry Kim; Eunyoung Choi; James R Goldenring; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  2020-02-28       Impact factor: 7.370

10.  Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.

Authors:  Victoria G Weis; Christine P Petersen; Jason C Mills; Pamela L Tuma; Robert H Whitehead; James R Goldenring
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-04       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.